CONFIRMED SPEAKERS

Rafael Alfonso, Director, Analytics and Innovation, Value Evidence and Outcomes, G.S.K.

Rafael Alfonso at Pharma Pricing and Market Access USA 2017

Bhakti Arondekar, Senior Director, Global & US Immuno/Oncology Team Leader, Outcomes & Evidence, Pfizer

Bhakti Arondekar at Pharma Pricing and Market Access USA 2017

James Barbeau, Director of Clinical Pathology, Lifespan/Brown University

James Barbeau at Pharma Pricing and Market Access USA 2017

Elise Berliner, Ph.D., Director, Technology Assessment Programme, Agency for Healthcare Research and Quality - U.S. Department of Health and Human Services

Bruce Broad, Clinical Professor of Dermatology at Perelman School of Medicine, University of Pennsylvania

Bruce Broad at Pharma Pricing and Market Access USA 2017

Catherine Brownstein, Scientific Director, Manton Center for Orphan Disease Research

Catherine Brownstein at Pharma Pricing and Market Access USA 2017

Anna Bucsics, External Lecturer, MoCA EU board member, University of Vienna

Anna Bucsics at Pharma Pricing and Market Access USA 2017

John Cai, Director, Medical Informatics, Celgene

John Cai at Pharma Pricing and Market Access USA 2017

Steve Clark, Vice President of Business Development and Consulting, Optum Life Sciences

Steve Clark at Pharma Pricing and Market Access USA 2017

Jerry Conway, Vice President of Reimbursement and Payer Strategy, Foundation Medicine Inc

Aimee Coughlin, Consultant, Optum Life Sciences

Aimee Coughlin at Pharma Pricing and Market Access USA 2017

Keely Dahl, Medical Affairs and Strategy Fellow, Novo Nordisk

Keely Dahl at Pharma Pricing and Market Access USA 2017

David Davidovic, Former Vice President & Global Head, Commercial Services, Roche Genentech

David Davidovic at Pharma Pricing and Market Access USA 2017

Peter Dehnel, Medical Director, Blue Cross and Blue Shield of Minnesota

Peter Dehnel at Pharma Pricing and Market Access USA 2017

Tao Fan, Director of Evidence Based Medicine and Medical Affairs, Sanofi Inc

Tao Fan at Pharma Pricing and Market Access USA 2017

Bill Goodson, Deputy Director of Pricing Reimbursement and Patient Assistance, Eisai Inc

Andy Gunn, Global Head Evidence Generation, UCB Pharma

Andy Gunn at Pharma Pricing and Market Access USA 2017

James Harnett, Sr. Director, Analytical Sciences Lead, Real World Data and Analytics, Global Health and Value, Pfizer

James Harnett at Pharma Pricing and Market Access USA 2017

Katherine Hempstead, Senior Adviser to the Executive Vice President, Robert Wood Johnson Foundation

Katherine Hempstead at Pharma Pricing and Market Access USA 2017

Athula Herath, Global Head of Real world Evidence Disease Epidemiology, Novartis

Athula Herath at Pharma Pricing and Market Access USA 2017

Peter Hull, Post-Doc at Microsoft Research, M.I.T

Peter Hull at Pharma Pricing and Market Access USA 2017

Jonathan Jarrow, Senior Medical Advisor to the Center Director of CDER, F.D.A

Jonathan Jarrow at Pharma Pricing and Market Access USA 2017

Sachin Kamal-Bahl, Vice President & Head, Global Health & Value Innovation Center, Pfizer

Sachin Kamal-Bahl at Pharma Pricing and Market Access USA 2017

Adam Kautzner, Vice President, Formulary & Drug Trends Solutions, Express Scripts

Adam Kautzner at Pharma Pricing and Market Access USA 2017

Dan Klein, President and Chief Executive Officer, Patient Access Network Foundation

Olaf Koester, Director, Manitoba Health

Brett Kopelan, Executive Director, DebRa of America

Brett Kopelan at Pharma Pricing and Market Access USA 2017

Shanthy Krishnaraja, Head of Global Health Economics and Reimbursement Strategy, C.S.L. Behring

Shanthy Krishnaraja at Pharma Pricing and Market Access USA 2017

Julie Locklear, Vice President and Head of Health Economics and Outcomes Research, EMD Serono

Julie Locklear at Pharma Pricing and Market Access USA 2017

Christine Lu, Co-Director of the PRecisiOn Medicine Translational Research (PROMoTeR) Center, Harvard Pilgrim Health Care

Christine Lu at Pharma Pricing and Market Access USA 2017

Steinar Madsen, Medical Director, Norwegian Medicines Agency, Norway

Steinar Madsen at Pharma Pricing and Market Access USA 2017

Bill Martin, Vice President, Pharma Strategy and Account Management, Express Scripts and Accredo

Bill Martin at Pharma Pricing and Market Access USA 2017

Christina Matteucci, Market Access Head, Bristol Myers Squibb

Christina Matteucci at Pharma Pricing and Market Access USA 2017

john mattison, CHIO, Asst Med Dir, Kaiser Permanente

john mattison at Pharma Pricing and Market Access USA 2017

Kevin Mayo, Ex Senior Director, Global Patient (Market) Access - Commerical Strategy and Consumer Operations, Shire Pharmaceuticals

Kevin Mayo at Pharma Pricing and Market Access USA 2017

Michele McCourt, Director, Cancer Care Co-Payment Assistance Foundation

Sean McElligott, Director, Market Access, Janssen

Sean McElligott at Pharma Pricing and Market Access USA 2017

Jim McKay, Director, Clinical Development and Medical Affairs, Sandoz

Jim McKay at Pharma Pricing and Market Access USA 2017

Timothy Miller, President, Chief Executive Officer and Director, Abeona Therapeutics Inc.

Timothy Miller at Pharma Pricing and Market Access USA 2017

Matthew Monberg, Director and Value Evidence Lead, Merck and Company

Matthew Monberg at Pharma Pricing and Market Access USA 2017

Jeff Myers, CEO, Medicaid Health Plans of America

Jeff Myers at Pharma Pricing and Market Access USA 2017

Douglas Nanton, Market Access and Government Affairs - Western Canada and Ottawa, Valeant Pharmaceuticals International

Douglas Nanton at Pharma Pricing and Market Access USA 2017

David Nash, MD MBA, Dean/Board of Directors, Jefferson College of Population Health

David Nash, MD MBA at Pharma Pricing and Market Access USA 2017

Amy Niles, Vice President, External Affairs, Patient Access Network Foundation P.A.N.

Amy Niles at Pharma Pricing and Market Access USA 2017

Bob Orzechowski, Chief Operating Officer, Lancaster Cancer Centre

Bob Orzechowski at Pharma Pricing and Market Access USA 2017

Melissa Paige, UVA Cancer Center, Oncology Patient Access Principal Coordinator, Patient Advocate, U.V.A. Health System

Melissa Paige at Pharma Pricing and Market Access USA 2017

Sachin Palod, Vice President, Access & Value Solutions, Life Sciences, Optum Life Sciences

Sachin Palod at Pharma Pricing and Market Access USA 2017

Leena Patel, Director of Development, Patient Access Network Foundation

Leena Patel at Pharma Pricing and Market Access USA 2017

Edmund Pezalla, Former VP Pharmaceutical Policy and Strategy, Aetna

Edmund Pezalla at Pharma Pricing and Market Access USA 2017

Tanya Potashnik, Director Policy and Economic Analysis Branch, Patented Medicine Prices Review Board, Goverment Of Canada

Tanya Potashnik at Pharma Pricing and Market Access USA 2017

S D Ravetkar, Executive Director, Serum Institute of India Ltd

S D Ravetkar at Pharma Pricing and Market Access USA 2017

Michael Reilly, Executive Director, Alliance for Safe Biologic Medicines

Michael Reilly at Pharma Pricing and Market Access USA 2017

John Shea, Director Corporate Development, Merck & Co Inc

John Shea at Pharma Pricing and Market Access USA 2017

Vanja Sikirica, Senior Director of Value Evidence and Outcomes, GlaxoSmithKline

Vanja Sikirica at Pharma Pricing and Market Access USA 2017

Vanja Sikirica, Senior Director of Value Evidence and Outcomes, GlaxoSmithKline

Vanja Sikirica at Pharma Pricing and Market Access USA 2017

Jamie Skipper, Former, ONC - Patient Centered Outcomes Research/HIT Policy, HSS

David Smith, Professor of Laboratory Medicine And Pathology, Mayo Clinic

David Smith at Pharma Pricing and Market Access USA 2017

Lotte Steuten, Associate Faculty Member, Fred Hutchinson Cancer Research Center

Dr Boxiong Tang, Senior Director, Teva Pharmaceuticals United State of America

Nadia Turchetta, Executive Director, Biopharmaceuticals, Sandoz Canada

Christine Verini, Chief Business Development Officer, CancerCare

Christine Verini at Pharma Pricing and Market Access USA 2017

Meredith Wadman, Policy Reporter, American Association for the Advancement of Science (AAAS)

Meredith Wadman at Pharma Pricing and Market Access USA 2017

Surrey Walton, Associate Professor of Pharmacy Administration, U.I.C.

Christina Waters, President & Chief Executive Officer, R.A.R.E. Science

Christina Waters at Pharma Pricing and Market Access USA 2017

James Wu, Senior Manager, Global Health Economics, Amgen Inc

James Wu at Pharma Pricing and Market Access USA 2017